Healthcare Professional’s Experiences & Perceptions of Switching Brands of oral SACT – Survey

Dear BOPA members

In cancer care, little is known about the impact of specific brands of oral SACT medication or how healthcare professionals respond and process brand switches of oral SACT. To understand this, we would like to gather the views of healthcare professionals involved in cancer care, on their perspectives and experiences on brand switching of oral SACT. Insights will be combined with data from the NIHR-funded SWITCH project, to improve cancer treatment delivery.

We would be very grateful if you would complete this online survey, which will take 10-15 minutes, by scanning the QR code or through this link: https://qualtrics.ucl.ac.uk/jfe/form/SV_dj0l16wIjCFIbWe

If you have any problems please email Pinkie Chambers : [email protected]

We would like responses by November 28th

Many thanks
Jessica Lim

4th Year MPharm Student, UCL School of Pharmacy

Supervisors: Dr Pinkie Chambers, Dr Zoe Moon, Rebecca Todd

Latest News

By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article
By BOPA Executive Committee on 30th October 2026

Acute and Supportive Oncology Clinical Consensus Statement

BOPA welcomes the Acute and Supportive Oncology Clinical Consensus Statement, to which we were pleased to contribute. It will be a benchmark for the sector, bringing direction and consistency as…

Read article
By BOPA, COSA, CAPhO & ISOPP on 13th October 2026

International Debate Webinar: Eastern and Western Medicine Can Co-exist – part of London Global Cancer Week 2026

Monday 2 November 2026 | 21:00 GMT (check your local time) Part of London Global Cancer Week 2026 Can Eastern and Western medicine co-exist in modern cancer care? Or do…

Read article
By Joseph Williams on 8th October 2026

BOPA 2026 Mentioned in Pharmaceutical Journal

Invest in aseptic services for future of specialised medicines, says chief pharmacist – The Pharmaceutical Journal Aseptic facilities are “absolutely essential” for hospitals to be involved in clinical trials and…

Read article